The promise of 3,4-methylenedioxymethamphetamine (MDMA) in combination with prolonged exposure therapy for posttraumatic stress disorder.
Barbara O RothbaumJessica L Maples-KellerPublished in: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2022)